Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China-Huadong
Hangzhou, Zhejiang, China
- Ownership
- Private
- Employees
- ~12000
- Development stage
- Other
01
Overview
Huadong Medicine is a leading Chinese pharmaceutical company headquartered in Hangzhou, specializing in the research, development, manufacturing, and distribution of pharmaceutical products and medical aesthetics. The company has a robust presence in therapeutic areas such as oncology, immunology, nephrology, and diabetes, with a significant focus on innovative biologics and antibody-drug conjugates (ADCs). Through its subsidiary Sinclair, Huadong is also a global player in the medical aesthetics market. The company operates an integrated business model that combines internal R&D with strategic global partnerships and a large-scale commercial distribution network in China.
- Therapeutic areas
- NephrologyEndocrinologyCardiovascularDermatologyOncology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugatePeptidesRecombinant fusion proteinBiologic
- Industry
- Biotech
02
Partnerships
ImmunoGenProvention BioKiniksa PharmaceuticalsHeidelberg PharmaAshvattha TherapeuticsC4 Therapeutics
Beyond the preview
Go deeper on China-Huadong.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on China-Huadong.